Results 101 to 110 of about 1,498,034 (139)

Alirocumab <i>versus</i> Evolocumab on Cardiovascular Outcomes: A Systematic Review and Meta-analysis. [PDF]

Curr Cardiol Rev
Cleto AS, Schirlo JM, Machozeki J, Martins CM.   +3 more
europepmc   +1 more source

Current and Future Perspectives of LDL-C Lowering Therapies 2026. [PDF]

J Atheroscler Thromb
Tada H, Sakata K, Usui S, Takamura M.
europepmc   +1 more source

Comparative effectiveness of cholesteryl ester transfer protein (CETP) inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis and network meta-regression. [PDF]

Medicine (Baltimore)
Khalil I, Islam MR, Promi SA, Joy AD, Sayed MA, Acharjee D, Al-Shammari AS, Rahman MT, Abrar S, Bin Jamil TS, Taseen M, Biswas S, Mifty SK, Al-Badri SG, Debnath A, Hossain MI, Akter MM.   +16 more
europepmc   +1 more source

PCSK9 inhibitors in the management of hypercholesterolaemia after heart transplantation in the UK, a single centre observational study. [PDF]

Sci Rep
Akhtar W, Khan T, Neves E, Browne C, Tawil M, Lyster H, Dar O.   +6 more
europepmc   +1 more source

Nationwide LDL-C goal attainment in high-risk and very-high-risk patients in Denmark: real-world lipid management and simulated impact of guideline implementation. [PDF]

Open Heart
Mohamed AA, Rached R, Kantsø LR, Honore ET, Lauridsen BK, Fijolek A, Gislason G.   +6 more
europepmc   +1 more source

Evaluating fitness-for-use of electronic health records in ascertaining baseline characteristics and clinical outcomes in clinical trials: insights from the VESALIUS EHR demonstration project. [PDF]

Trials
Gouda P, Nelson AJ, Raman SR, Qualls LG, Hammill BG, Garg J, Benziger CP, Divakaran R, Nilles EK, Marsolo K, O'Brien EC.   +10 more
europepmc   +1 more source

Inclisiran in Chronic Kidney Disease Patients: A Real-World Experience.

Cardiorenal Med
Dello Strologo A, Franculli A, Saporito P, Miani N, Bellasi A, Lido P, Di Lullo L, Ronco C, Peverini P.   +8 more
europepmc   +1 more source

Detection and quantification of ezetimibe and its major glucuronide in patients with hepatic impairment via liquid chromatography-tandem mass spectrometry. [PDF]

J Pharm Biomed Anal
Farrera DO, Maloney MM, LaMadrid CS, Lenzen-Hammerel P, Radtke LR, Cherrington NJ.   +5 more
europepmc   +1 more source

Conundrum of Cholesterol Management and Health Implications of Low Cholesterol Levels: A Narrative Review. [PDF]

JNMA J Nepal Med Assoc
Bashyal S, Karki M, Shah D.
europepmc   +1 more source

Lipid-lowering therapy in patients with hypercholesterolemia in terms of the POLSCORE and SCORE2 scales. A single-center retrospective analysis. [PDF]

Cardiol J
Rogozik JK, Grabowski M, Główczyńska R.   +2 more
europepmc   +1 more source